AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Strengthening the VA Centers of Excellence
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
Taxation/Internal Revenue Code TAX
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
Health Issues HCR
S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| AMY KALOIDES New | Legislative Aid, Sen. Mark Dayton. |
| MATTHEW ROSS KERSCHNER New | — |
| NATALIE PONTZER New | — |
| ANDREW SCHWAB New | — |
Medicare/Medicaid MMM
S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| AMY KALOIDES New | Legislative Aid, Sen. Mark Dayton. |
| MATTHEW ROSS KERSCHNER New | — |
| NATALIE PONTZER New | — |
| ANDREW SCHWAB New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.